ARCHIVES

AACI Recommends Cancer Control Guideline Changes

This article is from The Cancer Letter archive.

Vol. 05 No. 06 | February 9, 1979

Download PDF Visit The Full Archive

Related Articles

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

July 8, 1994

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006

Latest Statistics Show Decline In Deaths From Breast Cancer

January 13, 1995

In Brief: Money Bill Awaits President’s Decisions; M.D. Anderson To Dedicate New Faculties

September 24, 1976